| Literature DB >> 27750198 |
Sunhee Kang1, Young Mi Kim2, Ryang Yeo Kim3, Min Jung Seo2, Zaesung No2, Kiyean Nam4, Sanghee Kim5, Jaeseung Kim6.
Abstract
The anti-tubercular activity of 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidin-1-yl)benzyl)imidazo [1,2-a]pyridine-3-carboxamide (Q203) is modified by varying its side chain. In this study, we synthesized Q203 analogues with different side chains and studied their effects on anti-tubercular activity. Many analogues showed good potency against M. tuberculosis replicating in liquid broth culture medium (extracellular activity) regardless of chain length and conformational changes. However, a polar character in the side chain region was unfavorable for anti-tubercular activity. The analogues, 25, 28, 35, and 36, displayed excellent activity against M. tuberculosis replicating inside macrophages (intracellular activity) and promising pharmacokinetic (PK) properties with high drug exposure level and long half-life. Copyright ÂEntities:
Keywords: Imidazo[1,2-a]pyridine-3-carboxamide (IPA); Pharmacokinetics; Q203; Structure-activity relationship (SAR); Tuberculosis
Mesh:
Substances:
Year: 2016 PMID: 27750198 DOI: 10.1016/j.ejmech.2016.09.082
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514